Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2021
Beximco launches Bexovid in Bangladesh
Beximco Pharmaceuticals launched Bexovid, a generic version of Pfizer's Covid-19 treatment Paxlovid, initially in Bangladesh.
2021
Beximco completes acquisition of majority stake in Sanofi Bangladesh
Beximco Pharmaceuticals completed its acquisition of a majority stake in Sanofi Bangladesh.
2021
Beximco Pharma launches Emorivir generic molnupiravir
Beximco Pharmaceuticals announced the launch of Emorivir, its branded generic version of molnupiravir, following emergency use authorisation by Bangladesh's Directorate General of Drug Administration.
2021
Beximco Pharma signs agreement to acquire majority stake in Sanofi Bangladesh
Beximco Pharmaceuticals signed a final agreement to acquire a 54.6% stake in Sanofi Bangladesh for over Tk 400 crore. The share handover had started; completion was to be confirmed in a further announcement.